These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 4866104)

  • 1. Cryptococcus neoformans. 3. Inhibition of phagocytosis.
    Bulmer GS; Sans MD
    J Bacteriol; 1968 Jan; 95(1):5-8. PubMed ID: 4866104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-encapsulated variant of Cryptococcus neoformans. II. Surface receptors for cryptococcal polysaccharide and their role in inhibition of phagocytosis by polysaccharide.
    Kozel TR
    Infect Immun; 1977 Apr; 16(1):99-106. PubMed ID: 326680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryptococcus neoformans. II. Phagocytosis by human leukocytes.
    Bulmer GS; Sans MD
    J Bacteriol; 1967 Nov; 94(5):1480-3. PubMed ID: 4862192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular fate of Cryptococcus neoformans.
    Tacker JR; Farhi F; Bulmer GS
    Infect Immun; 1972 Aug; 6(2):162-7. PubMed ID: 4569916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strain variation in antiphagocytic activity of capsular polysaccharides from Cryptococcus neoformans serotype A.
    Small JM; Mitchell TG
    Infect Immun; 1989 Dec; 57(12):3751-6. PubMed ID: 2680980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of cryptococcal polysaccharide to Cryptococcus neoformans.
    Kozel TR; Hermerath CA
    Infect Immun; 1984 Mar; 43(3):879-86. PubMed ID: 6365785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of phagocytosis by cryptococcal polysaccharide: dissociation of the attachment and ingestion phases of phagocytosis.
    Kozel TR; Mastroianni RP
    Infect Immun; 1976 Jul; 14(1):62-7. PubMed ID: 780279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Killing of cryptococcus neoformans by Staphylococcus aureus: the role of cryptococcal capsular polysaccharide in the fungal-bacteria interaction.
    Saito F; Ikeda R
    Med Mycol; 2005 Nov; 43(7):603-12. PubMed ID: 16396245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide.
    Granger DL; Perfect JR; Durack DT
    J Clin Invest; 1985 Aug; 76(2):508-16. PubMed ID: 3928681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of pathogenic constituents of Cryptococcus neoformans strains.
    Kagaya K; Yamada T; Miyakawa Y; Fukazawa Y; Saito S
    Microbiol Immunol; 1985; 29(6):517-32. PubMed ID: 3900645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant but not causal association between surface charge and inhibition of phagocytosis by cryptococcal polysaccharide.
    Kozel TR; Reiss E; Cherniak R
    Infect Immun; 1980 Aug; 29(2):295-300. PubMed ID: 7011970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptococcus neoformans: size range of infectious particles from aerosolized soil.
    Neilson JB; Fromtling RA; Bulmer GS
    Infect Immun; 1977 Sep; 17(3):634-8. PubMed ID: 332630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro.
    Diamond RD; Root RK; Bennett JE
    J Infect Dis; 1972 Apr; 125(4):367-76. PubMed ID: 4553080
    [No Abstract]   [Full Text] [Related]  

  • 14. Paradoxical role of capsule in murine bronchoalveolar macrophage-mediated killing of Cryptococcus neoformans.
    Levitz SM; DiBenedetto DJ
    J Immunol; 1989 Jan; 142(2):659-65. PubMed ID: 2521352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation of a hydrophobic surface from phagocytosis of encapsulated and non-encapsulated cryptococcus neoformans.
    Kozel TR
    Infect Immun; 1983 Mar; 39(3):1214-9. PubMed ID: 6341232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phagocytosis and killing of Cryptococcus neoformans by rat alveolar macrophages in the absence of serum.
    Bolaños B; Mitchell TG
    J Leukoc Biol; 1989 Dec; 46(6):521-8. PubMed ID: 2681492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phagocytosis of Cryptococcus neoformans by normal and thioglycolate-activated macrophages.
    Swenson FJ; Kozel TR
    Infect Immun; 1978 Sep; 21(3):714-20. PubMed ID: 361575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phagocytosis of Cryptococcus neoformans by alveolar macrophages.
    Bulmer GS; Tacker JR
    Infect Immun; 1975 Jan; 11(1):73-9. PubMed ID: 1090528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Capsule of Cryptococcus neoformans Modulates Phagosomal pH through Its Acid-Base Properties.
    De Leon-Rodriguez CM; Fu MS; Çorbali MO; Cordero RJB; Casadevall A
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30355667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of serum factors in the phagocytosis of weakly or heavily encapsulated Cryptococcus neoformans strains by guinea pig peripheral blood leukocytes.
    Ikeda R; Shinoda T; Kagaya K; Fukazawa Y
    Microbiol Immunol; 1984; 28(1):51-61. PubMed ID: 6374392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.